Total Payments
$8,836
2024 Payments
$1,049
Companies
40
Transactions
494
Medicare Patients
2,173
Medicare Billing
$244,549
Payment Breakdown by Category
Food & Beverage$7,895 (89.4%)
Travel$784.41 (8.9%)
Education$156.52 (1.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,895 | 484 | 89.4% |
| Travel and Lodging | $784.41 | 1 | 8.9% |
| Education | $156.52 | 9 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,699 | 97 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,582 | 116 | $0 (2024) |
| Inspire Medical Systems, Inc. | $912.34 | 5 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $568.61 | 34 | $0 (2024) |
| Mylan Specialty L.P. | $411.60 | 24 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $354.97 | 16 | $0 (2022) |
| United Therapeutics Corporation | $286.45 | 20 | $0 (2023) |
| GENZYME CORPORATION | $278.44 | 13 | $0 (2024) |
| Merck Sharp & Dohme LLC | $263.04 | 20 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $246.97 | 17 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,049 | 58 | GlaxoSmithKline, LLC. ($309.11) |
| 2023 | $2,242 | 81 | Inspire Medical Systems, Inc. ($912.34) |
| 2022 | $1,616 | 93 | AstraZeneca Pharmaceuticals LP ($604.15) |
| 2021 | $882.77 | 60 | AstraZeneca Pharmaceuticals LP ($265.30) |
| 2020 | $399.49 | 22 | Philips Electronics North America Corporation ($72.77) |
| 2019 | $1,243 | 83 | GlaxoSmithKline, LLC. ($324.93) |
| 2018 | $775.98 | 59 | GlaxoSmithKline, LLC. ($138.29) |
| 2017 | $628.77 | 38 | Sunovion Pharmaceuticals Inc. ($145.28) |
All Payment Transactions
494 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: Respiratory | ||||||
| 12/10/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: IMMUNOLOGY | ||||||
| 11/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: RESPIRATORY | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Respiratory | ||||||
| 11/19/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 11/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: Immunology | ||||||
| 10/31/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/30/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/30/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/21/2024 | INOGEN, INC. | INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH (Device) | Food and Beverage | Cash or cash equivalent | $8.62 | General |
| Category: OXYGEN CONCENTRATOR | ||||||
| 09/27/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $21.19 | General |
| Category: RESPIRATORY | ||||||
| 09/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: RESPIRATORY | ||||||
| 09/12/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: IMMUNOLOGY | ||||||
| 09/12/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $1.15 | General |
| Category: IMMUNOLOGY | ||||||
| 09/06/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: Respiratory | ||||||
| 09/05/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 09/02/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: RESPIRATORY | ||||||
| 08/14/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.19 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/02/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: IMMUNOLOGY | ||||||
| 08/01/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: RESPIRATORY | ||||||
| 08/01/2024 | INOGEN, INC. | INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH (Device) | Food and Beverage | Cash or cash equivalent | $8.35 | General |
| Category: OXYGEN CONCENTRATOR | ||||||
| 07/19/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: IMMUNOLOGY | ||||||
| 07/18/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 07/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: Respiratory | ||||||
| 06/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.92 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 585 | 730 | $215,786 | $61,225 |
| 2022 | 13 | 473 | 568 | $170,477 | $46,793 |
| 2021 | 16 | 624 | 739 | $230,705 | $65,979 |
| 2020 | 13 | 491 | 671 | $265,685 | $70,552 |
Total Patients
2,173
Total Services
2,708
Medicare Billing
$244,549
Procedure Codes
59
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 48 | 86 | $58,050 | $13,783 | 23.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 138 | 171 | $29,925 | $10,659 | 35.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 82 | 115 | $29,900 | $10,516 | 35.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 37 | 58 | $15,080 | $5,246 | 34.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 40 | 40 | $15,800 | $4,510 | 28.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 30 | 31 | $15,345 | $4,087 | 26.6% |
| G0398 | Home sleep study test (hst) with type ii portable monitor, unattended; minimum of 7 channels: eeg, eog, emg, ecg/heart rate, airflow, respiratory effort and oxygen saturation | Office | 2023 | 17 | 18 | $9,900 | $1,957 | 19.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 12 | 12 | $5,940 | $1,805 | 30.4% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2023 | 20 | 21 | $8,925 | $1,678 | 18.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 14 | 27 | $4,860 | $1,623 | 33.4% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 28 | 28 | $4,340 | $1,173 | 27.0% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 26 | 26 | $4,290 | $1,047 | 24.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 14 | 14 | $2,310 | $985.53 | 42.7% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 28 | 28 | $4,900 | $800.18 | 16.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 19 | 19 | $1,121 | $554.23 | 49.4% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Office | 2023 | 17 | 17 | $3,825 | $500.70 | 13.1% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 15 | 19 | $1,275 | $300.25 | 23.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 42 | 60 | $40,500 | $9,455 | 23.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 69 | 96 | $24,960 | $8,745 | 35.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 113 | 134 | $23,450 | $7,753 | 33.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 60 | 60 | $23,700 | $6,366 | 26.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 34 | 48 | $12,480 | $3,671 | 29.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 27 | 27 | $13,365 | $3,525 | 26.4% |
| G0398 | Home sleep study test (hst) with type ii portable monitor, unattended; minimum of 7 channels: eeg, eog, emg, ecg/heart rate, airflow, respiratory effort and oxygen saturation | Office | 2022 | 25 | 25 | $13,750 | $2,886 | 21.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 26 | 40 | $7,200 | $2,164 | 30.0% |
About Dr. Rakesh Alva, MD
Dr. Rakesh Alva, MD is a Pulmonary Disease healthcare provider based in Greensboro, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/22/2007. The National Provider Identifier (NPI) number assigned to this provider is 1093868929.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rakesh Alva, MD has received a total of $8,836 in payments from pharmaceutical and medical device companies, with $1,049 received in 2024. These payments were reported across 494 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($7,895).
As a Medicare-enrolled provider, Alva has provided services to 2,173 Medicare beneficiaries, totaling 2,708 services with total Medicare billing of $244,549. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Greensboro, NC
- Active Since 01/22/2007
- Last Updated 08/10/2021
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1093868929
Products in Payments
- INSPIRE (Device) $912.34
- BREZTRI (Drug) $881.53
- NUCALA (Biological) $609.25
- DUPIXENT (Biological) $512.51
- TRELEGY ELLIPTA (Drug) $463.48
- OFEV (Drug) $374.91
- TEZSPIRE (Biological) $261.15
- TYVASO (Drug) $226.57
- YUPELRI (Drug) $223.53
- ZERBAXA (Drug) $217.96
- AIRSUPRA (Drug) $201.04
- Xolair (Biological) $195.01
- ANORO (Drug) $187.97
- GLASSIA (Biological) $184.99
- SYMBICORT (Drug) $171.05
- AREXVY (Drug) $162.11
- XOLAIR (Biological) $151.29
- Arikayce (Drug) $149.08
- FASENRA (Biological) $146.33
- UTIBRON (Drug) $135.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Greensboro
Dr. Praveen Mannam, M.d, M.D
Pulmonary Disease — Payments: $9,028
Pulmonary Disease $9,028
Adewale Olalere, Md, MD
Pulmonary Disease — Payments: $5,872
Pulmonary Disease $5,872
Dr. Wesam Yacoub, M.d, M.D
Pulmonary Disease — Payments: $403.92
Pulmonary Disease $403.92
Dr. Robert Brookman, D.o, D.O
Pulmonary Disease — Payments: $13.29
Pulmonary Disease $13.29